首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
產業/市場分類
生物科技 (1470)
分子標靶治療學 (51)
生技設備 (321)
生物材料 (55)
生物標記 (157)
以基因為基之藥物開發 (201)
再生醫學 (120)
抗體和免疫 (187)
個人化醫學 (54)
基因治療學和RNAi (101)
市場調查報告書

美國的 RNAi 市場

U.S. RNAi Markets

出版商 Frost & Sullivan
出版日期 2006年05月 商品編碼 38426
內容資訊 英文  
價格
US $ 6000 Web Access (Regional License)
US $ 6500 Hard Copy & Web Access (Regional License)


美國的 RNAi 市場 是由出版商Frost & Sullivan在2006年05月所出版的。 這份英文市場調查報告書價格從美金6000起跳。

簡介

專門於多様高科技產業相關策略性調查的美國調查公司 Frost & Sullivan (總公司:德州),針對美國的 RNA (核醣核酸)干涉市場進行詳細調查與分析,並出版調查報告書 "U.S. RNAi Markets" 。

本報告書內容包括:美國的 RNAi 市場各領域別的市場發展/阻礙因素、趨勢、市場未來預測、競爭結構等調查分析結果。內容綱要摘記如下:

第1章 實施概要

  • 市場簡介
    • 介紹

第2章 RNAi 整體市場

  • 市場簡介
    • 介紹
    • 調查範圍與區隔
    • 調查方法論
    • 評價
  • 市場未來預測與競爭分析
    • 收益預測
    • 競爭結構
    • 市場佔有率分析
    • 聯盟及合併・收購
  • 市場課題與策略性建議
    • 產業課題
    • 策略性建議
  • Frost & Sullivan Awards
    • Growth Strategy Leadership Award
    • Technology Leadership Award
    • Product Innovation Award
    • Customer Value Leadership Award

第3章 RNAi 成分的市場

  • 市場簡介
    • 介紹
    • 評價
  • 市場發展/阻礙因素
    • 市場之主要發展因素
    • 市場之主要阻礙因素
  • 技術與市場趨勢
    • 技術趨勢
    • 市場趨勢
  • 市場未來預測與競爭分析
    • 收益預測
    • 競爭結構
    • 市場佔有率分析

第4章 RNAi 傳遞工具市場

  • 市場簡介
    • 介紹
    • 評價
  • 市場發展/阻礙因素
    • 市場之主要發展因素
    • 市場之主要阻礙因素
  • 技術與市場趨勢
    • 技術趨勢
    • 市場趨勢
  • 市場未來預測與競爭分析
    • 收益預測
    • 競爭結構
    • 市場佔有率分析

第5章 RNAi 掃描與分析工具市場

  • 市場簡介
    • 介紹
    • 評價
  • 市場發展/阻礙因素
    • 市場之主要發展因素
    • 市場之主要阻礙因素
  • 技術與市場趨勢
    • 技術趨勢
    • 市場趨勢
  • 市場未來預測與競爭分析
    • 收益預測
    • 競爭結構
    • 市場佔有率分析

第6章 決策支援資料庫

  • 決策支援資料庫
    • 製藥企業的 R&D 支出
    • 政府對生物科技的 R&D 投資
    • 民間對生物科技的 R&D 投資
    • 生物科技企業的數量
    • 畢業生與異業後的發展

目錄

Abstract

Research Overview

This analysis is available through our Drug Discovery Technologies Growth Partnership Services program. With this program, clients receive industry-leading market research such as this, along with technical and econometric data and many interactive features including Analyst Inquiry Time and Client Councils.

Technologies

The following technologies are covered in this research:

  • Custom, pre-designed, or validated siRNA; siRNA sets; genome-wide libraries;
  • shRNA; expression cassettes; miRNA
  • Lipid-based transfection reagents; RNAi-specific transfection reagents;
  • electroporation devices and buffers; viral vectors; nano-particle technologies
  • Quantitative real time PCR assays; Northern blot kits; gene expression arrays;
  • western blot kits; 2D gel electrophoresis consumables; proteomics arrays;
  • phenotypic assays

Market Overview

The U.S. RNAi markets are rapidly evolving as a growing number of scientists transition their research focus from low-throughput to medium- and high-throughput in one dimension, and from in vitro to in vivo in a second dimension. Numerous opportunities exist for vendors of RNAi content and tools, especially as technologies advance to provide greater selectivity and specificity of knockdown. RNAi technologies are proving to be indispensable tools for functional genomics research and for identifying and validating potential drug targets. RNAi has become a vital tool for examining both gene and protein expression analyses, especially with regards to understanding the pre- and post-transcriptional function of genes in relation to disease. Using RNAi, researchers are able to simply turn genes on and off and observe what happens, thereby gaining insights into how genes participate in cellular processes. RNAi is by far the most widely used gene-silencing technique employed in research.

Table of Contents

  • 1. Executive Summary
    • 1. Market Overview
      • 1. Introduction
  • 2. Total RNAi Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Scope and Segmentation
      • 3. Research Methodology
      • 4. Market Engineering Measurements
    • 2. Market Forecast and Competitive Analysis
      • 1. Revenue Forecasts
      • 2. Competitive Structure
      • 3. Market Share Analysis
      • 4. Partnerships and Mergers & Acquisitions
    • 3. Market Challenges and Strategic Recommendations
      • 1. Industry Challenges
      • 2. Strategic Recommendations
  • 3. RNAi Content Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Market Engineering Measurements
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Technology and Market Trends
      • 1. Technology Trends
      • 2. Market Trends
    • 4. Market Forecasts and Competitive Analysis
      • 1. Revenue Forecasts
      • 2. Competitive Structure
      • 3. Market Share Analysis
  • 4. RNAi Delivery Tools Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Market Engineering Measurements
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Technology and Market Trends
      • 1. Technology Trends
      • 2. Market Trends
    • 4. Market Forecasts and Competitive Analysis
      • 1. Revenue Forecasts
      • 2. Competitive Structure
      • 3. Market Share Analysis
  • 5. RNAi Screening and Analysis Tools Market
    • 1. Market Overview
      • 1. Introduction
      • 2. Market Engineering Measurements
    • 2. Market Drivers and Restraints
      • 1. Market Drivers
      • 2. Market Restraints
    • 3. Technology and Market Trends
      • 1. Technology Trends
      • 2. Market Trends
    • 4. Market Forecasts and Competitive Analysis
      • 1. Revenue Forecasts
      • 2. Competitive Structure
      • 3. Market Share Analysis
  • 6. Decision Support Database
    • 1. Decision Support Database
      • 1. Pharmaceutical R&D Expenditure
      • 2. Government R&D Investment in Biotechnology
      • 3. Private Investment in Biotechnology
      • 4. Number of Biotechnology Companies
      • 5. Students Enrolled for Graduation and Postgraduation Courses
  • List of Figures
    • Total RNAi Markets: Revenue Forecasts (U.S.), 2002-2012
    • Total RNAi Markets: Revenues Forecasts by Segment (U.S.), 2002-2012
    • Total RNAi Markets: Percent of Revenues by Segment (U.S.), 2002-2012
    • Total RNAi Markets: Competitive Structure (U.S.), 2005
    • Total RNAi Markets: Company Market Share by Revenues (U.S.), 2005
    • Total RNAi Markets: Impact of Top Industry Challenges (U.S.), 2006-2012
    • Total RNAi Markets: Challenges and Corresponding Strategic Recommendations (U.S.), 2006-2012
    • RNAi Content Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
    • RNAi Content Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
    • RNAi Content Market: National Institutes of Health RNAi Related Funding (U.S.), 2006
    • RNAi Content Market: Revenue Forecasts (U.S.), 2002-2012
    • RNAi Content Market: Revenues Forecasts by Sub-Segment (U.S.), 2002-2012
    • RNAi Content Market: Percent of Revenues by Sub-Segment (U.S.), 2002-2012
    • RNAi Content Market: Competitive Structure (U.S.), 2005
    • RNAi Content Market: Company Market Share by Revenues (U.S.), 2005
    • RNAi Delivery Tools Market: Market Drivers Ranked in Order of Impact (U.S.), 2006-2012
    • RNAi Delivery Tools Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
    • RNAi Delivery Tools Market: Revenue Forecasts (U.S.), 2002-2012
    • RNAi Delivery Tools Market: Competitive Structure (U.S.), 2005
    • RNAi Delivery Tools Market: Company Market Share by Revenues (U.S.), 2005
    • RNAi Screening and Analysis Tools Market: Market Drivers Ranked in Order of Impact U.S.), 2006-2012
    • RNAi Screening and Analysis Tools Market: Market Restraints Ranked in Order of Impact (U.S.), 2006-2012
    • RNAi Screening and Analysis Tools Market: Revenue Forecasts (U.S.), 2002-2012
    • RNAi Screening and Analysis Tools Market: Competitive Structure (U.S.), 2005
    • RNAi Screening and Analysis Tools Market: Company Market Share by Revenues (U.S.), 2005
Back to Top